Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kip A. West, John Brognard, Amy S. Clark, Ilona R. Linnoila, Xiaowei Yang, Sandra M. Swain, Curtis Harris, Steven Belinsky, Phillip A. Dennis
Published in Volume 111, Issue 1
J Clin Invest. 2003; 111(1):81–90 doi:10.1172/JCI16147
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

Nicotine-mediated Akt activation and survival of NHBEs. (a) Topoisomerase II inhibition. Nicotine (10 μM) protected against etoposide-induced apoptosis, as assessed by flow cytometry. Pretreatment with LY294002 decreased nicotine-mediated survival. Parallel samples were harvested for immunoblotting (inset; C, control; N, nicotine; LY, LY294002; LY/N, LY294002 + nicotine). (b) UV irradiation. Nicotine (10 μM) protected against UV irradiation–induced apoptosis, as measured using CellDeath ELISA kits. Pretreatment with LY294002 or DHβE attenuated nicotine-mediated survival. (c and d) H2O2 treatment. NHBEs were pretreated with nicotine (10 μM) (c) or NNK (d) as above, with or without H2O2 (200 μM). After 4 hours, cells were harvested, dead cells that exhibited cytoplasmic inclusion of 0.4% trypan blue were counted, and this number was compared with the total number of cells. At least 300 cells per sample were counted by a blinded observer.